Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING

Untethered Microgrippers Sample Biologic Tissue

By BiotechDaily International staff writers
Posted on 13 May 2013
Image: A single μ-gripper next to a catheter (Photo courtesy of Johns Hopkins University).
Image: A single μ-gripper next to a catheter (Photo courtesy of Johns Hopkins University).
A new study describes thermally activated microgrippers that can reach narrow conduits in the body and be used to excise tissue for diagnostic analyses and biopsies.

Researchers at Johns Hopkins University (JHU; Baltimore, MD, USA) designed the submillimeter endoscopic microgrippers (μ-grippers) to resemble biological appendages, such as hands, with rigid phalanges and flexible joints. The residual stress powered actuators allow them to close and grasp without the need for tethers, while the rigid phalanges of the μ-grippers are composed of nickel, and hence, respond to an applied magnetic field. A thermo-sensitive polymer trigger layer on the joints keeps the μ-grippers flat at 4 °C, but softens at 37 °C, causing the μ-grippers to close.

The μ-grippers are small enough that hundreds can be deployed at a time and actuated en masse, and could therefore form the basis for a more statistically efficient means to screen large surface area organs such as the colon. To test the feasibility of biologic tissue sampling with μ-grippers, the researchers used a swine colon in ex vivo studies. They uniformly spread hundreds of μ-grippers by rotating the endoscope during the deployment. The arms of each millimeter-long μ-gripper is composed of chromium and gold actuators that naturally want to bend inwards, but are held back by the thin layer of polymer coating.

To simulate the normal human temperature, the colon was submerged in a water bath kept at 37 °C, whereupon the coating dissolved and the talons snatched up cells at close proximity; the researchers then visually verified the closure of the μ-grippers using endoscopic imaging. After closure, the vast majority of μ-grippers were retrieved using a magnetic catheter inserted through the endoscope. The researchers found that the μ-grippers identified the lesion 45% of the time; when the swarm was boosted up to 1,500 μ-grippers, the efficiency rose to 95%. The study was published in the April 2013 issue of Gastroenterology.

“Our results suggest a new paradigm in medicine whereby large numbers of small, tether-free microsurgical tools could complement individual, large, tethered biopsying devices,” concluded lead author Evin Gultepe, PhD, and colleagues of the department of chemical and biomolecular engineering. “The tissue retrieved by the μ-grippers is of sufficient quality and quantity to allow DNA and RNA extraction, as well as polymerase chain reaction (PCR) amplification in an effort to look for previously identified disease-diagnostic markers.”

Related Links:

Johns Hopkins University



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Illustration of the apoER2 receptor protein shows the structure of the entire protein in detail (Photo courtesy of Wikimedia Commons).

Risk of Cardiovascular Disease Linked to Apolipoprotein E Variants

The apoE4 variant form of circulating apolipoprotein E (apoE) leads to increased risk of cardiovascular disease by blocking binding of the normal apoE3 form to the apoliprotein E receptor 2 (apoER2) in... Read more

Drug Discovery

view channel
Image: S-649266 has more robust antibacterial activity than established antibiotics against multidrug-resistant bacteria (Photo courtesy of Shionogi).

Novel Antibiotic Shows Potential for Broad Range of Infections

The emergence of bacterial resistance to known antibacterial agents is becoming a major challenge in treating the infection caused by multi drug resistant (MDR) bacteria. In order to treat bacterial... Read more

Business

view channel

Collaboration of Mayo Clinic and IBM Cognitive Computer Devised to Improve Clinical Trial Research

The Mayo Clinic (Rochester, MN, USA) and IBM (Armonk, NY, USA) recently announced plans to pilot Watson, the IBM cognitive computer, to match patients more rapidly with suitable clinical trials. A proof-of-concept phase is currently ongoing, with the intent to introduce it into clinical use in early 2015.... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.